Sex differences in innate immunity and its impact on opioid pharmacology
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Morphine has been and continues to be one of the most potent and widely used drugs for the treatment of pain. Clinical and animal models investigating sex differences in pain and analgesia demonstrate that morphine is a more potent analgesic in males than in females. In addition to binding to the neuronal μ‐opioid receptor, morphine binds to the innate immune receptor toll‐like receptor 4 (TLR4), located on glial cells. Activation of glial TLR4 initiates a neuroinflammatory response that directly opposes morphine analgesia. Females of many species have a more active immune system than males; however, few studies have investigated glial cells as a potential mechanism driving sexually dimorphic responses to morphine. This Mini‐Review illustrates the involvement of glial cells in key processes underlying observed sex differences in morphine analgesia and suggests that targeting glia may improve current treatment strategies for pain. © 2016 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Sex, gender, and pain: a review of recent clinical and experimental findings
Fillingim, R. B., King, C. D., Ribeiro-Dasilva, M. C., Rahim-Williams, B., & Riley, J. L. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.12.001 · Cited by 2,766
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535 · cited 1×
“…induces the expression of both pro- and anti-inflammatory molecules such as cytokines (interleukins [IL]-1, -6, and -10; tumor necrosis factor-a [TNFa]), chemokines, cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), and reactive oxygen species (Bonizzi and Karin, 2004; Doyle and O’Neill, 2006).”
BackgroundGender variations in clinical pain experience
Unruh, A. M. (1996) · Pain · doi:10.1016/0304-3959(95)00214-6 · Cited by 1,550
Different immune cells mediate mechanical pain hypersensitivity in male and female mice
Sorge, R. E., Mapplebeck, J. C. S., Rosen, S., Beggs, S., Taves, S., Alexander, J. K., Martin, L. J., Austin, J.-S., Sotocinal, S. G., Chen, D., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4053 · Cited by 1,442 · cited 2×
“In the presence of testosterone, or in the absence of adaptive immune cells, females switch to the male-like TLR4dependent pathway (Sorge et al., 2015).”
BackgroundSex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon
Mogil, J. S. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3360 · Cited by 1,065
Microglia and neuroinflammation: a pathological perspective
Streit (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-14 · Cited by 1,039
Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985 · cited 5×
“…downregulate GABAA receptors, upregulate AMPA receptors, and increase extracellular concentrations of glutamate and K1, producing a net increase in neural excitability (Ogoshi et al., 2005; Stellwagen et al., 2005; Watkins et al., 2005; Yan et al., 2014; for review see Tilleux and Hermans, 2007).”
BackgroundInfluentialA Gender Gap in Autoimmunity: Task Force on Gender, Multiple Sclerosis and Autoimmunity
Whitacre, C. C., Reingold, S. C., O'Looney, P. A., Blankenhorn, E., Brinley, F., Collier, E., Duquette, P., Fox, H., Giesser, B., Gilmore, W., et al. (1999) · Science · doi:10.1126/science.283.5406.1277 · Cited by 851 · cited 4×
“Estradiol also has a well-documented biphasic effect on immune function in both preclinical and clinical studies (Whitacre et al., 1999; Nilsson, 2007; Straub, 2007), and its pro- or anti-inflammatory effects are dependent on dose, time, and method of testing (in vitro vs. in vivo).”
BackgroundInfluentialTumor necrosis factor alpha: A link between neuroinflammation and excitotoxicity
Olmos, G., & Lladó, J. (2014) · Mediators of Inflammation · doi:10.1155/2014/861231 · Cited by 730 · cited 12×
“Sex differences in glial activation likely contribute to the observed differences in NMDA and GABA signaling (for review see Ji et al., 2013).”
BackgroundInfluential
Cited by
Considering sex as a biological variable will require a global shift in science culture
Shansky, R. M., & Murphy, A. Z. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00806-8 · Cited by 428
Self-citationPain in Women: A Perspective Review on a Relevant Clinical Issue that Deserves Prioritization
Casale, R., Atzeni, F., Bazzichi, L., Beretta, G., Costantini, E., Sacerdote, P., & Tassorelli, C. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00244-1 · Cited by 159
“Another topic of research is whether the response to pain therapy is gender-related [47, 48].”
BackgroundSex differences in pain responses
Sorge, R. E., & Strath, L. J. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.05.006 · Cited by 73
Pando, M. M., Debner, E. K., Jacobs, B. A., Jamshidi, R. J., Jennings, E. M., Clarke, W. P., & Berg, K. A. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110326 · Cited by 5
Metadata
- Authors
- Doyle, H. H., & Murphy, A. Z.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2016-11-07
- Volume
- 95
- Issue
- 1-2
- Pages
- 487-499
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2554089026
- Cited by
- 55
- References
- 23
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.